Results 111 to 120 of about 2,836,766 (304)

Whole-Body End-Effector Pose Tracking

2025 IEEE International Conference on Robotics and Automation (ICRA)
Combining manipulation with the mobility of legged robots is essential for a wide range of robotic applications. However, integrating an arm with a mobile base significantly increases the system’s complexity, making precise end-effector control challenging.
Tifanny Portela, Andrei Cramariuc, Mayank Mittal, Marco Hutter 0001   +3 more
openaire   +2 more sources

Design of a passive robotic end effector for perpendicularity adjustment on curved surfaces

reservedEsistono molte applicazioni in cui è richiesto il posizionamento ortogonale dell’utensile rispetto alla superficie, dal campo medico (ad esempio ecografie o chirurgia mininvasiva) al campo aeronautico (ad esempio per operazioni di foratura o ...
BETTO, ALBERTO
core  

Pneumatic inflatable end effector

, 1981
The invention relates to an end effector device for robot or teleoperated type space vehicle which includes an inflatable balloon member carried on the end of tubular member which has a hollow center or conduit through which a suitable pressurized fluid ...
Clark, K. H., Johnston, J. D.
core  

Modelling stem cell differentiation related processes—A practical overview for biologists

FEBS Letters, EarlyView.
Stem cell differentiation is complex and difficult to control experimentally. This review introduces suitable computational modelling approaches that can support stem cell research, from mechanistic ODE and abstract models to multiscale and deep learning methods.
Ricco Zeegelaar, Xinqi Yan, Lucas Jansen Klomp, Stefano Schivo, Janine N. Post   +4 more
wiley   +1 more source

Mixed‐class J‐domain protein scaffolds promote expanded aggregate handling and multivalent Hsp70 engagement during functional disaggregase assembly

FEBS Letters, EarlyView.
Protein aggregates threaten proteostasis and cell health. In human cells, Hsp70–J‐domain protein‐based disaggregases remove aggregates, but how they assemble remains unclear. Our biochemical findings show that DNAJA2‐ and DNAJB1‐containing disaggregase scaffolds enhance luciferase aggregate targeting, and that Hsp70 recruitment by both J‐domain ...
Anna Szlachcic, Nadinath B. Nillegoda
wiley   +1 more source

Design of end effector for handling with glass stopper

, 2014
The diploma thesis deals with the structural design of the end effector for handling with the glass stopper of the hydrogen reactor of high temperature semiconductor diffusion furnace.
Hrnko, Lukáš
core   +1 more source

Tip and vibration control of space robots using estimated flexible coordinates

Frontiers in Space Technologies
This paper provides an extension to previous work on end-effector control of flexible space manipulators. Those works considered the use of a special output called the μ-tip rate for feedback control of desired end-effector trajectories with simultaneous
Dhruvi Patel, Christopher J. Damaren
doaj   +1 more source

The role of miR‐335‐5p in the redifferentiation of BRAF p.V600E thyroid cancers

Molecular Oncology, EarlyView.
The BRAF p.V600E mutation promotes thyroid cancer dedifferentiation and radioiodine resistance. Using a network approach, we identified miR‐335‐5p as a key regulator of BRAF‐mutated thyroid tumors. Restoring miR‐335‐5p increased thyroid‐specific gene expression and iodine uptake in cells and organoids.
Valeria Pecce, Simone Bini, Marialuisa Sponziello, Giorgio Grani, Giulia Fiscon, Paola Paci, Lorenzo Farina, Rosa Falcone, Valentina Maggisano, Sebastiano Filetti, Cosimo Durante, Antonella Verrienti   +11 more
wiley   +1 more source

Surface analyst end effector for industrial robot

, 2022
WSU inventors: Waruna Seneviratne, Dept. of Aerospace Engineering, College of Engineering; John Tomblin, Caleb Saathoff, and Upul Palliyaguru, NIAR.Application No: 18/049419 filed October 25, 2022.
Palliyaguru, Upul R., Saathoff, Caleb, Tomblin, John S., Seneviratne, Waruna P.   +3 more
core  

TRAIL‐PEG‐Apt‐PLGA nanosystem as an aptamer‐targeted drug delivery system potential for triple‐negative breast cancer therapy using in vivo mouse model

Molecular Oncology, EarlyView.
Aptamers are used both therapeutically and as targeting agents in cancer treatment. We developed an aptamer‐targeted PLGA–TRAIL nanosystem that exhibited superior therapeutic efficacy in NOD/SCID breast cancer models. This nanosystem represents a novel biotechnological drug candidate for suppressing resistance development in breast cancer.
Gulen Melike Demirbolat, Aslihan Kucuk, Omer Erdogan, Samed Ozer, Bensu Kozan, Tugba Cuceli, Erkan Gumus, Evrim Cevik, Ozge Cevik   +8 more
wiley   +1 more source